-

HSBC HOLDINGS (00005.HK)  -1.150 (-1.425%)    Short selling $210.20M; Ratio 8.804%   declared the second interim dividend for 2014 of US$0.10 per ordinary share to be payable on 9 October 2014. (Quote is delayed for at least 15 mins.Short Selling Data as at 2014-09-30 16:25.)

Comments

Post a Comment

Popular posts from this blog

-
Hopewell Hold (00054) sells Hopewell Infr stake for $9.9B  Hopewell Holdings (00054) has agreed to sell 2.055 billion shares of Hopewell Highway Infrastructure (00737) , representing 66.69% of the issued share capital of the company, to Shenzhen Investment International Capital Holdings Infrastructure Co. to HK$9.865 billion in cash, or HK$4.8 per share, which has a discount of 3.61% to the closing price of HK$4.98 per share on 29 December 2017. Upon completion of the deal, the purchaser and parties acting in concert with it will own a total of 66.69% stake in Hopewell Highway Infrastructure and the purchaser will be required to make an unconditional mandatory cash offer for all other issued shares of Hopewell Highway Infrastructure also at HK$4.8 per share. The total consideration of the offer will be HK$4.927 billion assuming full acceptance of the offer. The offeror intends to maintain Hopewell Highway Infrastructure's share listing following the close of...
Read more
-
Image
HAECO (00044.HK) 2017 Loss $540M, 2nd Interim Div. $0.5   AECO (00044.HK)    -0.250 (-0.530%)      Short selling $18.92K; Ratio 2.633%     announced annual results for the period ended 31 December 2017. The loss amounted to $541 million, against the profit of $975 million in the year-ago period. Loss per share equaled $3.25. A second interim dividend of $0.5 was declared.
Read more
-
PRADA Deutsche Bank believed and hoped PRADA (01913.HK)    -0.150 (-0.312%)    Short selling $12.87M; Ratio 35.577%   's performance had reached bottom in the third quarter. Looking ahead for the fourth quarter, with the Asian business getting back to normal, relatively low base in the second half of the year and the launch of new products, the company's sales growth may accelerate. Given the expected negative trend of the company's revenue, coupled with deleveraging, the company's EPS forecasts for FY2014-2015 were further cut by 7% and 5% respectively. The Hold rating was maintained and target price was reduced from $55 to $54. 
Read more